MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-03-2026
Intuitive Surgical Market Cap 2011-2026 | ISRG
As of April 14, 2026 Intuitive Surgical has a market cap of $ 167 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Intuitive Surgical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 171 B | 203 B | 133 B | 87 B | 103 B | 86.2 B | 65.9 B | 57.8 B | 47.8 B | 26.4 B | 20.1 B | 18.2 B | 16.7 B | 22.8 B | 17.9 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 203 B | 16.7 B | 71.8 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical instruments industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
1.56 B | $ 29.35 | 2.41 % | $ 1.4 B |  USA |
 |
Atrion Corporation
ATRI
|
639 M | - | - | $ 810 M | USA |
 |
iRhythm Technologies
IRTC
|
5.08 B | $ 123.37 | 2.42 % | $ 3.95 B | USA |
 |
Repro Med Systems
KRMD
|
199 M | $ 4.28 | -1.38 % | $ 198 M | USA |
 |
Luminex Corporation
LMNX
|
1.27 B | - | - | $ 1.75 B | USA |
 |
Microbot Medical
MBOT
|
120 M | $ 2.46 | 4.47 % | $ 113 M |  Israel |
 |
Akers Biosciences, Inc.
AKER
|
809 K | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
42.6 B | $ 80.49 | 0.94 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
26.1 M | $ 9.75 | 1.25 % | $ 23.7 M | USA |
 |
Haemonetics Corporation
HAE
|
3.06 B | $ 60.04 | 1.3 % | $ 3.02 B | USA |
 |
Envista Holdings Corporation
NVST
|
4.83 B | $ 27.34 | 1.6 % | $ 4.59 B | USA |
 |
Pro-Dex
PDEX
|
150 M | $ 52.9 | 0.96 % | $ 174 M | USA |
 |
The Cooper Companies
COO
|
16.3 B | $ 71.78 | 0.1 % | $ 14.3 B | USA |
 |
Retractable Technologies
RVP
|
20.1 M | $ 0.7 | -0.01 % | $ 21 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
727 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.27 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
152 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
STERIS plc
STE
|
24.2 B | $ 224.77 | -0.04 % | $ 22.2 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
15.6 B | - | -0.02 % | $ 16.3 B | USA |
 |
Harvard Bioscience
HBIO
|
20.9 M | $ 4.72 | 1.4 % | $ 210 M | USA |
 |
Teleflex Incorporated
TFX
|
5.44 B | $ 124.57 | 1.13 % | $ 5.56 B | USA |
 |
electroCore
ECOR
|
55.6 K | $ 6.52 | 3.74 % | $ 55.3 K | USA |
 |
Isoray
ISR
|
24.5 M | - | 0.03 % | $ 108 M | USA |
 |
Utah Medical Products
UTMD
|
199 M | $ 67.1 | -0.07 % | $ 217 M | USA |
 |
Glaukos Corporation
GKOS
|
4.3 B | $ 120.34 | 0.71 % | $ 5.83 B | USA |
 |
Masimo Corporation
MASI
|
8.96 B | $ 178.42 | -0.03 % | $ 9.51 B | USA |
 |
ICU Medical
ICUI
|
3.67 B | $ 130.35 | 0.8 % | $ 3.21 B | USA |
 |
Milestone Scientific
MLSS
|
23.8 M | $ 0.29 | 2.68 % | $ 23.8 M | USA |
 |
InfuSystem Holdings
INFU
|
146 M | $ 9.82 | 0.92 % | $ 203 M | USA |
 |
Merit Medical Systems
MMSI
|
4.85 B | $ 71.32 | 1.06 % | $ 4.22 B | USA |
 |
Predictive Oncology
POAI
|
553 K | - | - | $ 31.1 M | USA |
 |
LeMaitre Vascular
LMAT
|
2.54 B | $ 115.83 | 0.57 % | $ 2.62 B | USA |
 |
BioLife Solutions
BLFS
|
1.14 B | $ 20.33 | 1.09 % | $ 937 M | USA |
 |
Baxter International
BAX
|
9.65 B | $ 17.95 | 1.79 % | $ 9.21 B | USA |
 |
ResMed
RMD
|
35.1 B | $ 231.43 | 0.51 % | $ 33.8 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
2.52 B | $ 12.3 | 2.29 % | $ 2.45 B | USA |
 |
Pulse Biosciences
PLSE
|
1.7 B | $ 19.6 | 3.59 % | $ 1.32 B | USA |
 |
Stereotaxis
STXS
|
171 M | $ 1.96 | 2.08 % | $ 178 M | USA |
 |
STAAR Surgical Company
STAA
|
941 M | $ 26.27 | -2.12 % | $ 1.3 B | USA |
 |
NeuroMetrix
NURO
|
8.71 M | - | 5.05 % | $ 9.02 M | USA |
 |
West Pharmaceutical Services
WST
|
17.6 B | $ 263.74 | 1.45 % | $ 19.1 B | USA |
 |
AngioDynamics
ANGO
|
355 M | $ 10.57 | 3.22 % | $ 432 M | USA |
 |
Becton, Dickinson and Company
BDX
|
56.2 B | $ 155.79 | 0.23 % | $ 44.8 B | USA |
 |
Nephros
NEPH
|
22.5 M | $ 2.87 | -1.37 % | $ 29.8 M | USA |
 |
OraSure Technologies
OSUR
|
235 M | $ 3.15 | 2.11 % | $ 231 M | USA |
 |
Repligen Corporation
RGEN
|
10.8 M | $ 126.59 | 3.26 % | $ 7.05 M | USA |